Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Prevalence of polycystic … - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Prevalence of polycystic ovary syndrome in women with severe obesity - Effects of a structured weight loss programme

Artikel i vetenskaplig tidskrift
Författare Josefin Kataoka
Ingrid Larsson
Sofia Björkman
Björn Eliasson
Johanna Schmidt
Elisabet Stener-Victorin
Publicerad i Clinical Endocrinology
ISSN 0300-0664
Publiceringsår 2019
Publicerad vid Institutionen för neurovetenskap och fysiologi, sektionen för fysiologi
Institutionen för medicin
Institutionen för kliniska vetenskaper, Avdelningen för obstetrik och gynekologi
Språk en
Länkar dx.doi.org/10.1111/cen.14098
Ämnesord hyperandrogenemia, lipids, metabolic syndrome, polycystic ovary syndrome diagnosis, prevalence, bone-mineral density, metabolic syndrome, cardiovascular-disease, follow-up, risk, predictors, overweight, criteria, adults, mass, Endocrinology & Metabolism
Ämneskategorier Obstetrik och kvinnosjukdomar

Sammanfattning

Objective Existing data are contradictory on the prevalence of polycystic ovary syndrome (PCOS) and metabolic syndrome (MetS) in women with severe obesity (body mass index [BMI] >= 35 kg/m(2)), and there are few studies investigating the effect of weight reduction in women with severe obesity and PCOS. The aim was to study the prevalence of PCOS and MetS among women with severe obesity and to evaluate the effect of a 12-months weight loss programme on the prevalence of PCOS and MetS. Design/Participants In total, 298 women with severe obesity were enrolled whereof 246 women had complete screening data for PCOS and MetS before commencing treatment. Weight loss intervention included very low energy diet. At 12-months follow-up, 72 women with complete data remained and were re-examined with baseline parameters. Results At baseline, the prevalence of PCOS was 25.6% and in this group, the prevalence of MetS was 43.4% in PCOS vs 43.3% in controls (ns). At 12-months follow-up, weight loss in women with PCOS was 12.3 +/- 10.7 kg (P < .001) and in non-PCOS 13.9 +/- 13.4 kg (P < .001) with no between group difference. Women without PCOS decreased in total bone mass. Conclusions Polycystic ovary syndrome occurs in one out of four women with severe obesity. The prevalence of MetS does not differ between women with or without PCOS with severe obesity. There was a significant weight loss in both groups but no difference between groups regarding change in metabolic parameters.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?